Moreover, transfection of LAPTM4B cDNA promotes proliferation, migration, invasion and multidrug resistance in HCC and GBC cells [18]–[22], and knockdown of LAPTM4B by RNAi reverses multiple malignant phenotypes [19], [22]. This evidence concerns the gene LAPTM4B and hepatocellular carcinoma.